AB-106

· Nuvation Bio Inc

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for AB-106, covering 2024-11-21 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AB-106 in Subjects With Advanced NSCLC Harboring ROS1 Fusion Gene [Phase 2]